Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grupo SURA
Medellín, Antioquia, Colombia
- Ownership
- Private
- Development stage
- Other
01
Overview
Grupo SURA is a Colombian financial services group focused on insurance, pensions, savings, investments, and asset management rather than being a pure life sciences, biotech, pharma, or healthcare operating company. The name "SURA" most commonly refers to this active public holding company and insurance group. While SURA has sponsored healthcare-related innovation through its subsidiary-backed creation of VaxThera, SURA itself is not primarily a drug developer or life sciences company. For biotech analysts, the important distinction is that "SURA" is the parent financial/insurance group, whereas VaxThera is the biotechnology company associated with it.
- Industry
- Investors
Beyond the preview
Go deeper on Grupo SURA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Grupo SURA.